Whalegun
Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 04/15

Trade details

Type
Insider sale
Amount
$373,099.32
Shares · price
14,058 sh · $26.54 a share
Held after
76,140 sh
Stock
Mineralys Therapeutics MLYS
Person
David Malcom RodmanChief Medical Officer
Trade date
26/04/13
Filed
26/04/15
Days to filing
2 days

Sold 15.6% of holdings

Share of holding sold
15.6%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 03/14~05/13

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13